Drouin Z, Levesque F, Mouzakitis K, Labrie M
Clin Exp Metastasis. 2024; 42(1):5.
PMID: 39694975
DOI: 10.1007/s10585-024-10318-x.
Martinez-Bernabe T, Pons D, Oliver J, Sastre-Serra J
Biomolecules. 2024; 14(11).
PMID: 39595536
PMC: 11591675.
DOI: 10.3390/biom14111359.
Li B, Tian J, Zhang F, Wu C, Li Z, Wang D
Nat Commun. 2024; 15(1):9417.
PMID: 39482286
PMC: 11528051.
DOI: 10.1038/s41467-024-53771-8.
Doelker T, Gallwas J, Grundker C
Cancer Genomics Proteomics. 2024; 21(6):566-579.
PMID: 39467628
PMC: 11534035.
DOI: 10.21873/cgp.20473.
Claudio-Ares O, Luciano-Rodriguez J, Del Valle-Gonzalez Y, Schiavone-Chamorro S, Pastor A, Rivera-Reyes J
Inorganics (Basel). 2024; 12(1).
PMID: 39380574
PMC: 11460773.
DOI: 10.3390/inorganics12010026.
Soloxolone -methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition and inhibits growth of U87 glioblastoma xenografts in mice.
Odarenko K, Senkova A, Salomatina O, Markov O, Salakhutdinov N, Zenkova M
Front Pharmacol. 2024; 15:1428924.
PMID: 39135794
PMC: 11317440.
DOI: 10.3389/fphar.2024.1428924.
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition.
Gorji-Bahri G, Krishna B, Hagerling C, Orimo A, Jirstrom K, Papadakos K
J Transl Med. 2024; 22(1):351.
PMID: 38615020
PMC: 11016227.
DOI: 10.1186/s12967-024-05083-0.
Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis.
Boudreault J, Wang N, Ghozlan M, Lebrun J
Cancers (Basel). 2024; 16(1).
PMID: 38201651
PMC: 10778361.
DOI: 10.3390/cancers16010224.
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models.
Guerrieri A, Bellotti C, Penzo M, Columbaro M, Pannella M, De Vita A
BMC Cancer. 2023; 23(1):1194.
PMID: 38057796
PMC: 10698968.
DOI: 10.1186/s12885-023-11658-9.
NANOG Dominates Interleukin-6-Induced Sphere Formation in Prostate Cancer.
Seven D, Tecimel D, Bayrak O
Urol Res Pract. 2023; 49(6):376-380.
PMID: 37987305
PMC: 10765223.
DOI: 10.5152/tud.2023.23116.
Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.
Yang X, Deng L, Diao X, Yang S, Zou L, Yang Q
iScience. 2023; 26(11):108218.
PMID: 37953954
PMC: 10637938.
DOI: 10.1016/j.isci.2023.108218.
Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.
Loris J, Hanesch L, Bauerschmitz G, Gallwas J, Grundker C
Int J Mol Sci. 2023; 24(18).
PMID: 37762008
PMC: 10530864.
DOI: 10.3390/ijms241813705.
Overcoming multidrug resistance by reversan and exterminating glioblastoma and glioblastoma stem cells by delivering drug-loaded nanostructure hybrid lipid capsules (nHLCs).
Hasan U, Chauhan M, Basu S, R J, Giri J
Drug Deliv Transl Res. 2023; 14(2):342-359.
PMID: 37587289
DOI: 10.1007/s13346-023-01401-z.
In Vitro Approaches to Determine the Potential Carcinogenic Risk of Environmental Pollutants.
Barguilla I, Maguer-Satta V, Guyot B, Pastor S, Marcos R, Hernandez A
Int J Mol Sci. 2023; 24(9).
PMID: 37175558
PMC: 10178670.
DOI: 10.3390/ijms24097851.
Advances in Brain Metastasis Models.
Lee J, Yang S
Brain Tumor Res Treat. 2023; 11(1):16-21.
PMID: 36762804
PMC: 9911715.
DOI: 10.14791/btrt.2022.0037.
RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes.
Thomas P, Srivastava S, Udayashankara A, Damodaran S, Yadav L, Mathew B
Cell Mol Life Sci. 2022; 80(1):1.
PMID: 36469134
PMC: 11073244.
DOI: 10.1007/s00018-022-04645-z.
Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells.
Ferrer A, Kenfack Y, Petryna A, Arap W, Pasqualini R, Rameshwar P
Oncoscience. 2022; 9:42-48.
PMID: 36110329
PMC: 9469806.
DOI: 10.18632/oncoscience.562.
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
Sarnella A, Ferrara Y, Auletta L, Albanese S, Cerchia L, Alterio V
J Exp Clin Cancer Res. 2022; 41(1):122.
PMID: 35365193
PMC: 8976345.
DOI: 10.1186/s13046-022-02345-x.
A protocol to enrich in undifferentiated cells from neuroblastoma tumor tissue samples and cell lines.
Amador-Alvarez A, Gomez-Munoz M, Rodriguez-Prieto I, Pardal R, Vega F
STAR Protoc. 2022; 3(2):101260.
PMID: 35345594
PMC: 8956940.
DOI: 10.1016/j.xpro.2022.101260.
Regulation of cancer stem cell activity by thyroid hormone receptor β.
Doolittle W, Zhu X, Park S, Zhu Y, Zhao L, Meltzer P
Oncogene. 2022; 41(16):2315-2325.
PMID: 35256781
PMC: 9018601.
DOI: 10.1038/s41388-022-02242-9.